PTH1R and breast carcinoma: PTH1R was found to correlate with reduced overall survival in breast cancer patients [98] and was detected in 37% of primary tumors, but 81% of the bone metastasis samples, supporting the role of the PTHrP/PTH1R system in breast cancer bone metastasis.